Synthesis and anticonvulsant activity of 1-acetyl-5-arylidenyl-3-(2′-oxo/thiobarbiturinyl)-2-pyrazolines;Synthese und antikonvulsive wirkung von 1-acetyl-5-arylidenyl-3-(2′-oxo/thiobarbiturinyl)-2-pyrazolinen

Arzneimittel-Forschung/Drug Research

Volumn 52, Issue 11, 2002, Pages 787-791

  Archana, ^a   Srivastava, Virendra Kishor ^a   Kumar, Ashok ^a  

^a LLRM MEDICAL COLLEGE   (India)

Author keywords

Oxybarbiturinyl derivatives, anticonvulsant activity, chalcones, pyrazolines, rat, synthesis; Thiobarbiturinyl derivatives, anticonvulsant activity, chalcones, pyrazolines, rat, synthesis

Indexed keywords

1 ACETYL 3 (2' OXOBARBITURINYL) 2 PYRAZOLINE DERIVATIVE; 1 ACETYL 3 (2' THIOBARBITURINYL) 2 PYRAZOLINE DERIVATIVE; 1 ACETYL 5 (4 METHOXYPHENYL) 3 (2' THIOBARBITURINYL) 2 PYRAZOLINE; ALDEHYDE; BARBITURIC ACID DERIVATIVE; CHALCONE DERIVATIVE; HYDRAZINE; PHENYL GROUP; PHENYTOIN; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYCLIZATION; DRUG POTENCY; DRUG SYNTHESIS; FEMALE; LD 50; MALE; NONHUMAN; POLYMERIZATION; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0036440304     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299968     Document Type: Article

References (15)

1. Drugs effective in the therapy of the epilepsies. Goodman & Gilman's "The Pharmacological Basis of Therapeutics", 9th Ed., p. 471, Mc Graw-Hill Co., New York (1996)
2. Drugs effective in the therapy of the epilepsies. Goodman & Gilmans "The Pharmacological Basis of Therapeutics", 9th Ed., p. 472, Mc Graw-Hill. Co., New York (1996)
3. Martin, O., Simon, Z., Nutiu, R. et al., Anticonvulsant barbiturate derivatives. Chem. Abstr. 132, 102398x (2000)
4. Osman, A. N., Kandeel, M. M., Ahmed, M., Synthesis and anticonvulsant activity of some spiro compounds derived from barbituric and thiobarbituric acids. Indian J. Chem. 35B, 1073 (1996)
5. Czuba, W., Kasperek, L., Prelicz, D. et al., Reaction products of dimethyl sulfoxide with 5,5-disubstituted barbituric acids and their biological properties. Chem. Abstr. 104, 141710j (1986)
6. Levitt, B., Stotar, M., Oxopyrimidine derivatives and pharmaceutical compositions containing them. Chem. Abstr. 103, 87713b (1985)
7. Youssef, K. M., Omar, R. H., El-Meleigy, S., Synthesis, CNS depressant and anticonvulsant activities of certain spiro thiobarbituric acid derivatives. Chem. Abstr. 124, 29690q (1996)
8. Gupta, K. P., Gupta, R. C., Bhargava, K. P. et al., Inhibition of brain respiration by new anticonvulsant benzylidene thiobarbiturates. Eur J. Med. Chem. 17, 448 (1982)
9. Taylor, C. R., Stauffer, H. F., Preparation for 3′-amino-5-methyl-1H-pyrazole-4-carboxylic acid and their esters as anticonvulsants, muscle relaxants and anxiolytics. Chem. Abstr. 111, 153796Z (1989)
10. Soni, N., Pande, K., Kalsi, R. et al., Inhibition of rat brain monoamine oxidase and succinic dehydrogenase of anticonvulsant pyrazolines. Res. Commun. Chem. Pathol. Pharmacol. 56, 129 (1987)
11. Tripathi, S., Pandey, B. R., Barthwal, J. P. et al., Novel indolyl pyrazolines as monoamine oxidase inhibitors. Indian J. Physiol. Pharmacol. 24, 155 (1980)
12. Bansal, E., Srivastava, V. K., Kumar, A., Synthesis and anti-inflammatory activity of 1-acetyl-5-substituted aryl-3-(β-amino naphthyl)-2-pyrazolines and β-(substituted aminoacetyl) amidoaphthalenes. Eur. J. Med. Chem. 36, 81 (2001)
13. Dusza, J. P., Joseph, J. P., Berstein, S., 3-Trifiuoroacetyl-amino-1-aryl-2-pyrazolines. Chem. Abstr. 101, 151839K (1984)
14. Smith, Q. E., Pharmacological Screening Tests Progress in Medicinal Chemistry 1. Butterworth, London (1960)
15. Tomen, J. E. P., Swinyard, E. A., Goodman, L. S., Properties of maximal seizures, and their alteration by anticonvulsant drugs and other agents. J. Neurophysiol. 9, 231 (1946)